Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in Hancock Whitney Corp, Disclosing 12.5% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 15 to Schedule 13G, confirming its beneficial ownership of 12.5% of Hancock Whitney Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 11.9% Passive Stake in Park Hotels & Resorts
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 11.9% of Park Hotels & Resorts Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, revealing a 12.5% beneficial ownership stake in Silicon Laboratories Inc., totaling over 4 million shares.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.7% Stake in Interpublic Group
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 10.7% beneficial ownership stake in Interpublic Group of Companies, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 11.8% Stake in Cousins Properties Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing an 11.8% beneficial ownership stake in Cousins Properties Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 16.3% of Sunrun Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.6% Stake in Collegium Pharmaceutical
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.6% in Collegium Pharmaceutical, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in National Vision Holdings, Discloses 15.4% Beneficial Ownership
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 15.4% beneficial ownership stake in National Vision Holdings, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.1% Stake in Neurocrine Biosciences
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 12.1% in Neurocrine Biosciences Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.1% Stake in Visteon Corp, Reaffirming Passive Investment Stance
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 12.1% beneficial ownership stake in Visteon Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 10.2% beneficial ownership stake in Mid-America Apartment Communities Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 13.4% beneficial ownership stake in DANA Inc's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.8% Stake in REX AMERICAN RESOURCES Corp
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.8% of REX AMERICAN RESOURCES Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Phibro Animal Health, Disclosing 15.7% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, reporting a 15.7% beneficial ownership stake in Phibro Animal Health Corp's Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Benchmark Electronics to 15.5%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 15.5% in Benchmark Electronics Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 15.2% beneficial ownership stake in TTM Technologies Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.1% Stake in Regency Centers Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 10.1% in Regency Centers Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 14.6% Stake in Addus HomeCare Corp
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 14.6% of Addus HomeCare Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Boise Cascade Co to 15.5%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 15.5% in Boise Cascade Co's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 13.4% beneficial ownership stake in G-III Apparel Group Ltd., held for passive investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 11.7% Stake in FB Financial Corp, Reinforcing Passive Investment Stance
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its continued beneficial ownership of 11.7% of FB Financial Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.3% of PROG Holdings, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 16.9% Stake in Summit Hotel Properties, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 16.9% of Summit Hotel Properties, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in New Jersey Resources Corp, Holding 15.3% of Common Stock
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reaffirming its substantial beneficial ownership of 15.3% in New Jersey Resources Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, disclosing an 11.8% beneficial ownership stake in ExlService Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, disclosing a 14.2% beneficial ownership stake in Nextracker Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 10.8% Stake in DoubleVerify Holdings, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 10.8% beneficial ownership stake in DoubleVerify Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 14.8% beneficial ownership stake in Archrock, Inc. common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 14.6% of Berkshire Hills Bancorp Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 15.2% beneficial ownership stake in AMERISAFE INC as of March 31, 2025.